The Hyper IgM Foundation Blog 

The Hyper IgM Foundation is proud to announce the availability of seed grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome. The intent of these grants is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on gene therapy/editing for CD40 Ligand Deficiency as well as hematopoietic stem cell transplantation for CD40 Ligand Deficiency.

During the 2019 calendar year, the Hyper IgM Foundation will be awarding one-time grants of up to $30,000 to worthy recipients. Grant applications for 2020 grants have a submission deadline of June 15th, 2020. (Please note, due to the COVID-19 crisis, we have extended the deadline from May 15th, 2020 to June 15th, 2020).

Complete and relevant proposals will be reviewed by the Hyper IgM Foundation’s Research Committee (RC), which may solicit feedback from members of the Hyper IgM Foundation’s Scientific Advisory Committee. Any conflicts of interest will be disclosed in the review minutes and will be reported on grant approvals.

For more information about grants submissions see our Research Grants page.

All inquiries should be submitted to the Hyper IgM Foundation by contacting [email protected].

Hyper IgM Foundation
215 W101st Street. Suite 7B
New York, NY 10025
United State of America
www.hyperigm.org